Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent DocsWill the Federal Circuit's Pfizer v. Teva Decision Spell the End of Amgen's Patent Rights to Recombinant Human Erythropoietin?
By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry
Full post as published by Patent Docs on April 01, 2008 (boomark / email).
Baseball Players Named in Mitchell Report
Major League Baseball Players using Performance Enhancing Drugs
California Supreme Court Proposition 8 Decision
Court Rejects Challenges to Proposition 8, but Finds Marriages Valid
Privacy Protection Act 42 USC 21A
Federal Newsroom Law
Bextra Product Recall
Find a Bextra Lawyer
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Cumulative Voting
Protecting minority shareholder interests
Civil / Human Rights
alleging violations of basic human and civil rights.
US Federal Government
allegedly violated the niversal Declaration of Human Rights by deporting undocumented parents of US born children.
FDA
Life-Threatening Complications Associated with Recombinant Human Bone Graft Products
Medical Technology Rights
Alphatec agrees to $11 million settlement in patent lawsuit.
Teva Animal Health Expands Ketamine Hydrochloride Recall
Teva Animal Health Expands Ketamine Hydrochloride Recall
Specialty Lamp International
Recalls Counterfeit Circuit Breakers

Is being pro-active a good thing
Pfizer Feels Pain Over Celebrex
Federal Circuit Invalidates Pfizer's Latest-Expiring Patent on Celebrex, for Double Patenting
District Court Upholds Validity of Pfizer's Accupril Patent, Rejecting Teva's Nonenablement Argument
Pharma Prosecution: CIP Breaks Priority for Restricted Claims
Takeda, Abbott whack Teva over Prevacid








